Optimising outcomes of hospital infections through appropriate empirical antimicrobial therapy. Introduction.
Lode
H
H
Research Center for Medical Studies, Institute for Clinical Pharmacology and Toxicology, Charitè-universitätsmedizin Berlin, Berlin, Germany. haloheck@zedat.fu-berlin.de
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D006090:Gram-Negative Bacteria / Q000187:drug effects; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents